Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
HC Yu, HJ Chen, YL Chang, CY Liu, CW Shiau… - Biochemical …, 2013 - Elsevier
Erlotinib is a small-molecular inhibitor of epidermal growth factor receptor (EGFR). Here, we
identify that cancerous inhibitor of protein phosphatase 2A (CIP2A) is a major determinant …
identify that cancerous inhibitor of protein phosphatase 2A (CIP2A) is a major determinant …
[HTML][HTML] Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients
D Krikelis, M Bobos, G Karayannopoulou… - BMC Clinical …, 2013 - Springer
Background Since scarce data exist on the pathogenesis of nasopharyngeal carcinoma in
Caucasian patients, we attempted to elucidate the responsible molecular pathways in this …
Caucasian patients, we attempted to elucidate the responsible molecular pathways in this …
[PDF][PDF] Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients
V Vassiliou, D Krikelis, M Bobos… - 2013 - bmcclinpathol.biomedcentral.com
Background: Since scarce data exist on the pathogenesis of nasopharyngeal carcinoma in
Caucasian patients, we attempted to elucidate the responsible molecular pathways in this …
Caucasian patients, we attempted to elucidate the responsible molecular pathways in this …